A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial for the Efficacy and Safety of a Novel Nutraceutical for Mild-to-Moderate Acne.

Although the percent decrease over time tended to be greater in the active group across the study duration, the difference between groups did not reach statistical significance in the change in non‐inflammatory lesions at week 12 ( p = 0.16, Figure 2b ).

also in 111,027 other papers